Drug recall · January 17, 2018
Docetaxel Injection USP recall
Why: Defective Container: Product complaints received of defect in the seal of the Docetaxel injection vials that the aluminum seal and/or stopper is removed when the cap is flipped off.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Docetaxel Injection USP, 20 mg/mL, One-Vial Formulation, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Visakhapatnam - 530 046 INDIA, NDC 43598-611-11
- Lots / codes
Lot #: H7044, Exp 05/19
- Quantity
- 1,051 vials
- Company
- Dr. Reddy's Laboratories, Inc., Princeton, NJ
- Distribution
- Distributed nationwide in the USA, Uzbekistan, and Myanmar
- Initiated
- January 9, 2017 · Voluntary: Firm initiated
- Classified
- January 12, 2018
- Reported
- January 17, 2018
- Ended
- December 4, 2018
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Docetaxel
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.